AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS RCEL 深 沪
等待开盘 09-04 09:30:00 美东时间
4.29
0.000
0.00%
华盛通- 最 高4.43
- 今 开4.26
- 成交量 15.23万股
- 最 低 4.22
- 昨 收 4.29
- 总市值 1.13亿
- 52周最高 14.16
- 市盈率 静 --
- 换手率 0.58%
- 52周最低 3.60
- 委 比 -15.76%
- 总股本 2643.47万
- 历史最高 49.11
- 量 比 0.77
- 振 幅 4.90%
- 历史最低 3.60
- 每 手 1
- 风险率 3.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AVITA Medical Announces September Investor Conference Participation
AVITA Medical announced that senior management will participate in three investor conferences in September 2025. The events include the Cantor Global Healthcare Conference on September 4 with CFO David O’Toole, the Morgan Stanley Global Healthcare Conference on September 8 with CEO Jim Corbett, and the Lake Street Capital Markets Best Ideas Growth Conference on September 11 with CFO David O’Toole. A live audio webcast of the Morgan Stanley firesi...
08-21 20:05
Avita Medical Announces $15M Equity Placement Agreement
An announcement from Avita Medical ( ($RCEL) ) is now available. On August 12, ...
08-19 05:52
AVITA Medical Successfully Completes Australian Equity Raise
AVITA Medical, Inc. successfully completed a private placement to raise approximately US$15 million via issuing 17.2 million New CDIs at A$1.32 each. The funds will support the company's therapeutic acute wound portfolio growth and operational flexibility until 2026. The placement reflects strong investor confidence and includes both new and existing Australian shareholders. The New CDIs are expected to begin trading on the ASX on August 20, 2025...
08-12 12:30
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical invites shareholders and investors to an investor webinar on August 14, 2025, at 9 AM AEDT (August 13 at 4 PM PDT). The webinar will cover Q2 2025 financial and business results, with a Q&A session. Register at [link]. AVITA, a leader in acute wound care, highlights its FDA-approved RECELL System for burn and trauma wound treatment, along with other products like PermeaDerm and Cohealyx. A replay will be available post-event. For mo...
08-10 23:00
D. Boral Capital Maintains Buy on AVITA Medical, Lowers Price Target to $18
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and lowers the price target from $19 to $18.
08-08 20:26
Avita Medical Amends Credit Agreement with OrbiMed
An announcement from Avita Medical ( ($RCEL) ) is now available. On August 7, 2...
08-08 05:43
AVITA Medical Q2 EPS $(0.38) Misses $(0.25) Estimate, Sales $18.42M Miss $22.61M Estimate
AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.25) by 53.23 percent. This is a 36.67 percent increase over losses of $(0.60) per share from
08-08 04:09
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
AVITA Medical to Announce Second Quarter 2025 Financial Results
AVITA Medical, Inc. announced it will report its Q2 2025 financial results after U.S. markets close on August 7, 2025. The company will host a conference call and webcast on August 8, 2025, at 6:30 a.m. Australian Eastern Standard Time (1:30 p.m. Pacific Time) to discuss its financial results and recent business highlights. The live webcast and replay will be available on the company's Investor Relations website. AVITA Medical is a leading therap...
07-28 20:05
